These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23974236)

  • 1. Compatibility of micafungin injection with other drugs during simulated y-site co-administration.
    Trusley C; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2006; 10(3):230-3. PubMed ID: 23974236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compatibility of caspofungin acetate injection with other drugs simulated y-site coadministration.
    Chan P; Heatherly K; Kupiec TC; Trissel LA
    Int J Pharm Compd; 2008; 12(3):276-8. PubMed ID: 23969719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incompatibilities of lansoprazole injection with other drugs during simulated y-site coadministration.
    Trissel LA; Saenz C; Williams KY; Ingram D
    Int J Pharm Compd; 2001; 5(4):314-9. PubMed ID: 23981922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compatibility screening of precedex during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA; Ingram DS; Williams KY; Retzinger JP
    Int J Pharm Compd; 2002; 6(3):230-3. PubMed ID: 23979190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility screening of bivalirudin during simulated y-site administration with other drugs.
    Trissel LA; Saenz CA
    Int J Pharm Compd; 2002; 6(4):311-5. PubMed ID: 23979308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compatibility screening of hextend during simulated y-site administration with other drugs.
    Trissel LA; Williams KY; Baker MB
    Int J Pharm Compd; 2001; 5(1):69-72. PubMed ID: 23981801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of Docetaxel with Selected Drugs during Simulated Y-Site Administration.
    Trissel LA; Gilbert DL; Wolkin AC
    Int J Pharm Compd; 1999; 3(3):241-4. PubMed ID: 23985624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compatibility screening of linezolid injection during simulated Y-site administration with other drugs and infusion solutions.
    Trissel LA; Williams KY; Gilbert DL
    J Am Pharm Assoc (Wash); 2000; 40(4):515-9. PubMed ID: 10932461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compatibility of doripenem with other drugs during simulated Y-site administration.
    Brammer MK; Chan P; Heatherly K; Trusley C; Kupiec TC; Trissel LA; Psathas PA; Gilmor T; Schaufelberger D
    Am J Health Syst Pharm; 2008 Jul; 65(13):1261-5. PubMed ID: 18574017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compatibility of allopurinol sodium with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Jul; 51(14):1792-9. PubMed ID: 7942908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compatibility of ceftaroline fosamil for injection with selected drugs during simulated Y-site administration.
    Singh BN; Dedhiya MG; DiNunzio J; Chan P; Kupiec TC; Trissel LA; Laudano JB
    Am J Health Syst Pharm; 2011 Nov; 68(22):2163-9. PubMed ID: 22058102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of granisetron hydrochloride with selected drugs during simulated Y-site administration.
    Trissel LA; Gilbert DL; Martinez JF
    Am J Health Syst Pharm; 1997 Jan; 54(1):56-60. PubMed ID: 9117791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compatibility of warfarin sodium with selected drugs and large-volume parenteral solutions.
    Martinez JF; Trissel LA; Gilbert DL
    Int J Pharm Compd; 1997; 1(5):356-8. PubMed ID: 23989380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compatibility of amifostine with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 Oct; 52(20):2208-12. PubMed ID: 8564592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compatibility of thiotepa (lyophilized) with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1996 May; 53(9):1041-5. PubMed ID: 8744467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration.
    Trissel LA; Saenz CA; Ogundele AB; Ingram DS
    Am J Health Syst Pharm; 2004 Nov; 61(21):2289-93. PubMed ID: 15552637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compatibility of aztreonam with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Health Syst Pharm; 1995 May; 52(10):1086-90. PubMed ID: 7656099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compatibility of filgrastim with selected drugs during simulated Y-site administration.
    Trissel LA; Martinez JF
    Am J Hosp Pharm; 1994 Aug; 51(15):1907-13. PubMed ID: 7524319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
    Housman ST; Tessier PR; Nicolau DP; Kuti JL
    Am J Health Syst Pharm; 2011 Dec; 68(23):2265-70. PubMed ID: 22095816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.